CollPlant Biotechnologies Ltd (NAS:CLGN)
$ 6.1 -0.09 (-1.45%) Market Cap: 69.87 Mil Enterprise Value: 47.39 Mil PE Ratio: 0 PB Ratio: 2.46 GF Score: 46/100

Q4 2022 Collplant Biotechnologies Ltd Earnings Call Transcript

Mar 29, 2023 / 02:00PM GMT
Release Date Price: $6.74 (-9.89%)
Operator

Welcome to the CollPlant Biotechnologies investor conference call to discuss financial results for the full-year 2022 and corporate updates. The question-and-answer session will follow the formal presentation. (Operator Instructions) Now I'd like to turn the call over to Dory Kurowski of LifeSci Advisors. Please go ahead, ma'am.

Dory Kurowski
LifeSci Advisors, LLC - Director, Investor Communications

Good morning. I would like to welcome everyone to CollPlant Biotechnologies' first financial results conference call for the full year ended December 31, 2022. With us on the call today from CollPlant are Yehiel Tal, Chief Executive Officer, who will provide an overview of the company's programs and forthcoming updates; and Eran Rotem, Chief Financial Officer, who will provide a summary of CollPlant's financial results for the full year ending December 31, 2022.

Before we get started, I would like to remind everyone that statements made on this conference call may include forward-looking statements. Actual events or results could differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot